Mesothelioma cancer research - malignant mesothelioma

Mesothelioma cancer research plays mesothelioma metastases here! played an integral role in the development of metastases mesothelioma # 1 site and the introduction of new treatments to combat malignant mesothelioma, cancer deaths that are still incurable. Traditional methods used to treat mesothelioma are similar to those used to treat other types of cancer and include surgery, chemotherapy and radiotherapy.

Mesothelioma studies have focused on the development of new chemotherapy drugs. Newly developed drugs must tolerate the clinical trials process, which ends with approval from the Food and Drug (FDA) and commercial distribution rights. Mesothelioma clinical trials, which have recently attracted much attention include those related Alimta (pemetrexed), Onconase (ranpirnase) and Veglin.

Mesothelioma metastasis

The most common type of malignant pleural mesothelioma is mesothelioma, cancer that causes tumor growth in the mesothelial tissue lining lung, oral cavity (pleura). Pleural mesothelioma often detected after suffering visit a doctor to complain of chronic chest pain, this pain is the result of accumulation of fluid within the pleural space and called pleural effusion.

Pleural mesothelioma often be wrong type of lung cancer because of the diseasea ˆ ™ s close proximity to the lungs. Pleural mesothelioma metastasis may lead to the development of secondary lung cancer, however, such secondary lung cancer disease, it would be his own, completely removed from cancer mesothelioma pleura.

Pleural mesothelioma metastatic language

2. Flores RM, Akhurst T, Gonen M, et al: Positron emission tomography defines metastatic disease, but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 126: 11-16, 2003

3. Erasmus JJ, Truong MT, Smythe WR, et al: Integrated computed tomography-Positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staged consequences. J Thorac Cardiovasc Surg 129: 1364-1370, 2005

6. Zanconati F, DelConte, Bonifacio-Gori D, et al: metastatic pleural mesothelioma presentation involving solitary language: Report on the new case and review of the literature. Int J Surg Pathol 11: 51-55, 2003

16. Rusch VW, Rosenzweig K, Venkatraman E, and others: the second phase of the trial of surgical resection and adjuvant high-dose radiation hemithoracic malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122: 788-795, 2001